Jeffrey H Wilkins

CIK 1779160 · View on SEC EDGAR ↗

Insider

First SEC filing: March 17, 2021 · Latest: March 17, 2021

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 10, 2021 AVTX P 912 $2.28 $2,079 27,002 Direct +3.50% Acquired -99.7% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Initial ownership (Form 3) 3 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
March 17, 2021 AVTX Common Stock 26,090 Direct
March 17, 2021 AVTX Stock Option (Right to Buy)→ Common Stock (375,000) 375,000 Direct
March 17, 2021 AVTX Stock Option (Right to Buy)→ Common Stock (300,000) 300,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

AVTX

M.D.(3)Former Chief Medical Officer
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2021 $425,000 — — $659,405 $165,580 — — $1,249,985
2020 $335,534 $178,000 — $974,244 — — — $1,487,778

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.